Medicare Enrolled
Dr. Kevin Lisman, MD
Interventional Cardiology · Houston, TX
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lisman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lisman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lisman
Dr. Kevin Lisman is an interventional cardiology in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lisman performed 11,787 Medicare services across 7,254 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lisman received a total of $13,936 from 49 pharmaceutical and/or device companies across 631 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lisman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in TX$ $13,936 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,787
Medicare services
Top 1% in TX for interventional cardiology
7,254
Unique beneficiaries
$175
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~589 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 3,020 | $44 | $118 |
| Office visit, established patient (30-39 min) | 1,937 | $91 | $145 |
| Echocardiogram, transthoracic | 1,111 | $133 | $1,345 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 789 | $51 | $575 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 744 | $609 | $1,952 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 614 | $1,061 | $3,250 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 476 | $21 | $110 |
| Remote pacemaker monitoring, 90 days | 439 | $23 | $94 |
| Hospital follow-up visit, high complexity | 364 | $96 | $175 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 313 | $21 | $125 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 243 | $4 | $85 |
| Injection, sulfur hexafluoride lipid microspheres, per ml | 235 | $14 | $30 |
| Office visit, established patient (20-29 min) | 211 | $51 | $110 |
| Ultrasound of both sides of head and neck blood flow | 209 | $145 | $650 |
| New patient office visit (45-59 min) | 124 | $113 | $396 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 112 | $1,937 | $5,897 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 89 | $203 | $669 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $10 | $40 |
| Initial hospital admission, moderate complexity | 72 | $105 | $167 |
| Heart muscle strain imaging | 62 | $30 | $100 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 57 | $127 | $521 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 55 | $69 | $491 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $352 | $2,115 |
| Electrocardiogram (EKG), 12-lead | 52 | $11 | $125 |
| Ultrasound of leg arteries or artery grafts | 51 | $173 | $784 |
| Initial hospital admission, high complexity | 42 | $137 | $300 |
| Cardiac catheterization | 37 | $198 | $1,500 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $20 | $65 |
| Ultrasound study of arm and leg arteries | 22 | $57 | $375 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $678 | $2,345 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $71 | $471 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 15 | $140 | $441 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $422 | $2,327 |
| External shock to heart to regulate heart beat | 14 | $81 | $440 |
| Hospital follow-up visit, moderate complexity | 14 | $64 | $150 |
| Coronary stent placement | 13 | $444 | $3,500 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 12 | $7 | $72 |
| Heart rhythm analysis and report of continous external ekg over more than 48 hours up to 7 days | 12 | $170 | $462 |
| New patient office visit (30-44 min) | 12 | $61 | $236 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $208 | $912 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.8% high complexity
44.5% medium
41.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,936
Total received (2018-2024)
Avg $1,991/year across 7 years
Top 33% in TX for interventional cardiology
49
Companies
631
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,936 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,939
2023$1,434
2022$2,332
2021$2,999
2020$1,550
2019$1,705
2018$1,978
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,617
BIOTRONIK INC.
$1,553
PFIZER INC.
$972
Amgen Inc.
$891
E.R. Squibb & Sons, L.L.C.
$849
Janssen Pharmaceuticals, Inc
$796
Novartis Pharmaceuticals Corporation
$619
Bolton Medical Inc
$355
Boston Scientific Corporation
$334
Merck Sharp & Dohme LLC
$307
SANOFI-AVENTIS U.S. LLC
$282
Astellas Pharma US Inc
$281
Esperion Therapeutics, Inc.
$278
AstraZeneca Pharmaceuticals LP
$231
Boehringer Ingelheim Pharmaceuticals, Inc.
$214
AngioDynamics, Inc.
$194
Medtronic Vascular, Inc.
$192
BOSTON SCIENTIFIC CORPORATION
$186
Medtronic, Inc.
$180
CARDIVA MEDICAL, INC.
$159
Edwards Lifesciences Corporation
$156
Acutus Medical, Inc.
$135
Amarin Pharma Inc.
$123
HeartFlow, Inc.
$108
Impulse Dynamics (USA) Inc.
$104
Aziyo Biologics, Inc.
$87
G Medical Diagnostic Services, Inc.
$75
Tactile Systems Technology Inc
$60
Sanara MedTech Inc.
$58
Novo Nordisk Inc
$47
Regeneron Healthcare Solutions, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$41
Gilead Sciences, Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$39
Biosense Webster, Inc.
$35
Lexicon Pharmaceuticals, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
CardioFocus, Inc.
$30
GE HEALTHCARE
$24
Merz North America, Inc.
$23
AltaThera Pharmaceuticals LLC
$22
Actelion Pharmaceuticals US, Inc.
$20
AGEPHA Pharma FZ LLC
$19
CVRx, Inc.
$18
Siemens Medical Solutions USA, Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
iRhythm Technologies, Inc.
$17
Philips Electronics North America Corporation
$13
Cardiovascular Systems Inc.
$13
Top 3 companies account for 44.1% of total payments
Associated products mentioned in payments ›
ACCENT · ACCOLADE SR · ALLURE QUADRA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · Acticor · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · CONFIRM RX · CRT-Ds · Cardiac Monitoring Suite · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carto 3 System · CellerateRx · Claria MRI · Confirm Rx · CorPath Imaging System · Corlanor · DRAGONFLY OPSTAR · ECM · ECM Patch · ELIQUIS · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · Edora · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FFRct · FORTIFY ASSURA · Flexitouch Plus · Grafts · HAWKONE · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · IGT_D Peripheral · INVOKANA · JARDIANCE · LEQVIO · LEXISCAN · LODOCO · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MITRACLIP · MRI Ready Leads · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Pouch · Quadra Assura CRT Defibrillator · Relay Grafts · Repatha · Resolute · Rivacor · SAPIEN 3 Ultra RESILIA · Solia · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · Verquvo · WAINUA · WATCHMAN · WATCHMAN FLX · XARELTO · XEOMIN · Xience Sierra Coronary Stent · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $118 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
62
Per 100K population
1.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lisman is a cardiac imaging specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lisman experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Lisman performed 3,020 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lisman receive payments from pharmaceutical companies?
Yes. Dr. Lisman received a total of $13,936 from 49 companies across 631 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lisman's costs compare to other interventional cardiologys in Houston?
Dr. Lisman's average Medicare payment per service is $175. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lisman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Houston
Browse interventional cardiologys in Houston ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology